Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Blasi, J. Garau, J. Medina, M. Ávila, K. McBride, H. Ostermann (Milan, Italy; Barcelona, Madrid, Spain; Zaventem, Belgium; Chatham, United States Of America; Munich, Germany). Community-acquired pneumonia in five European countries: Usage patterns and real-life effectiveness of antibiotics (REACH study). Eur Respir J 2012; 40: Suppl. 56, 4365

Member's Comments

No comment yet.

Related content which might interest you: Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals Source: Eur Respir J 2005; 26: Suppl. 49, 638s Year: 2005 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Community-acquired pneumonia mortality: a potential link to recent antibiotic prescribing trends in England and Wales Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 International Guideline concordance of empiric antibiotic use in community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017 Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018 Year: 2018 Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Burden of community-acquired pneumonia in Italian general practice Source: Eur Respir J 2013; 42: 1739-1742 Year: 2013 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Optimizing treatment for community-acquired pneumonia in Denmark (The optiCAP study) Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Severe community-acquired pneumonia in China: epidemiology and clinical practice Source: International Congress 2019 – Chinese programme 2019: Part II Year: 2019